Ammonia N 13 Injection, Solution
Product Images NDC 52670-552

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ammonia N 13 (NDC 52670-552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayo Clinic, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ammonia N 13 Injection Usp Is Provided As A Ready To Use Sterile, Pyrogen-free, Clear And Colorless Solution. Each mL Of The Solution Contains Between 0.138 Gbq To 1.387 Gbq (3.75 Mci To 37.5mci) Of [13n] Ammonia, At The End Of Synthesis (eos), In 0.9% Aqueous Sodium Chloride. The Ph Of The Solution Is Between 4.5 To 7.5. The Recommended Dose Of Radioactivity (0.368-0.736 Gbq, 10-20 Mci) Is Associated With A Theoretical Mass Dose Of 0.5-1.0 Picomoles (8.47-16.94 (Ammonia N 13 Usp 01)

Ammonia N 13 Injection Usp Is Provided As A Ready To Use Sterile, Pyrogen-free, Clear And Colorless Solution. Each mL Of The Solution Contains Between 0.138 Gbq To 1.387 Gbq (3.75 Mci To 37.5mci) Of [13n] Ammonia, At The End Of Synthesis (eos), In 0.9% Aqueous Sodium Chloride. The Ph Of The Solution Is Between 4.5 To 7.5. The Recommended Dose Of Radioactivity (0.368-0.736 Gbq, 10-20 Mci) Is Associated With A Theoretical Mass Dose Of 0.5-1.0 Picomoles (8.47-16.94 (Ammonia N 13 Usp 01)
FDA Label Image

Principal Display Panelndc 52670-552-30ammonia N13 Injection Uspintravenous Use Rx Only (Ammonia N 13 Usp 02)

Principal Display Panelndc 52670-552-30ammonia N13 Injection Uspintravenous Use Rx Only (Ammonia N 13 Usp 02)
NDC# 52670-552-30 is a sterile Ammonia N 13 Injection USP intended for intravenous use only as per prescription. It has an expiration of 30 minutes after End of Synthesis (EOS) and contains 0.9% re upnght. The product is manufactured by Mayo Clinic PET Radiochemistry Facility and must not be used if cloudy or contains particulate matter. The product has a shelf life of 10.0 minutes, and its concentration is measured as mCi/mi. The expiry date and time are also indicated on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.